anonymous
Guest
anonymous
Guest
Why would anyone want an ultra rare disease role at BI where you can’t get stock options, when every other rare disease company throws $100k in options at reps on the day of signing?
because there are respiratory reps looking to get away from PCP sales. They move over to the Derm sales roles, get some experience under their belt, then they move to a smaller start up that drops a boat load of high risk options in their lap.
easy.